0.9522

0.95 (-4.49%)

As of Jun 14, 2022

Neoleukin Therapeutics, Inc. [NLTX]

Source: 

Company Overview

Neoleukin Therapeutics, Inc. is a biopharmaceutical company that has focused on creating next generation immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. We developed sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins.

CountryUS
Headquartersseattlewashington
Phone Number(206) 732-2133
Industrypharmaceutical preparations
CEOJonathan G. Drachman
Websitewww.neoleukin.com

Recent Stories